demonstrated an increased frequency of BM-infiltrating immunosuppressive M2 macrophages expressing TIGIT, TIM-3, and LAG-3 in patients with newly diagnosed and relapsed AML (157). The gene discussed is TIGIT; the disease is acute myeloid leukemia.